Lewis William's Form 4 filing
INSMED Inc (INSM) · filed Jul 2, 2025
- Accession no.
- 0001402051-25-000003
- Filed
- Jul 2, 2025
- Trade date
- Jul 1, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $671.6K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lewis WilliamCIK 0001402051 | Director, Officer (Chair and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2025 | Common Stock | MOption exerciseAcquired | +6,830 | $10.85 | +$74,105.5 | 240,754 | Indirect | |
| Jul 1, 2025 | Common Stock | SSaleDisposed | −3,666 | $97.73F2 | −$358,278.18 | 237,088 | Indirect | |
| Jul 1, 2025 | Common Stock | SSaleDisposed | −2,349 | $98.83F3 | −$232,151.67 | 234,739 | Indirect | |
| Jul 1, 2025 | Common Stock | SSaleDisposed | −815 | $99.61F4 | −$81,182.15 | 233,924 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2025 | Common Stock | MOption exerciseDisposed | −6,830 | $0.00 | $0 | 20,525 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This is the weighted average sales price representing 3,666 shares sold at prices ranging from $97.40 to $98.38 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.
- F3
This is the weighted average sales price representing 2,349 shares sold at prices ranging from $98.40 to $99.39 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.
- F4
This is the weighted average sales price representing 815 shares sold at prices ranging from $99.40 to $100.26 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.